H1 Cancer Anorexia- Cachexia Syndrome Market 2017 Pipeline Report by Industry Overview, Development Landscape and Drug Profile
The Pipeline Assessment report on Cancer Anorexia-Cachexia Syndrome market analysis the major players involved in the development of Cancer Anorexia-Cachexia Syndrome drugs and list all their pipeline projects. The pipeline report encapsulates all the dormant and discontinued pipeline projects.
May 4, 2017 /MarketersMedia/ —
ReportsnReports.com adds Cancer Anorexia-Cachexia Syndrome – Pipeline Review, H1 2017 a new research reports in its store. The pipeline guide provides a snapshot of the global therapeutic landscape of Cancer Anorexia-Cachexia Syndrome (Oncology). The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
Browse the 24 Tables and 11 Figures, 10 Company Profiles, Spread across 98 Pages Report Available at http://www.reportsnreports.com/contacts/discount.aspx?name=944648 .
Cancer Anorexia-Cachexia Syndrome Companies Involved in Therapeutics Development are Acacia Pharma Ltd, Aeterna Zentaris Inc, Aphios Corp, Incyte Corp, Lakewood-Amedex Inc, Novartis AG, Obexia AG, PsiOxus Therapeutics Ltd, RaQualia Pharma Inc and Viking Therapeutics Inc.
Cancer Anorexia-Cachexia Syndrome Drug Profiles: (formoterol fumarate + megestrol acetate), anamorelin hydrochloride
Antibody to Inhibit Parathyroid Hormone Related Protein for Cancer Cachexia: AV-380, AVGN-7, C-1889, DLN-101, dronabinol, EXT-400, Foxo1-nRNA, HM-03, macimorelin acetate
Monoclonal Antibody to Antagonize TWEAK Receptor for Cachexia Drug Profile: MT-102, NEO-1940 and OBX-1201 Cancer Anorexia-Cachexia Syndrome Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Cancer Anorexia-Cachexia Syndrome (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Cancer Anorexia-Cachexia Syndrome (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Cancer Anorexia-Cachexia Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 4, 1, 1, 12 and 2 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 3 molecules, respectively.
Place Order to This Report at http://www.reportsnreports.com/purchase.aspx?name=944648 .
Cancer Anorexia-Cachexia Syndrome (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
The pipeline guide reviews pipeline therapeutics for Cancer Anorexia-Cachexia Syndrome (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Cancer Anorexia-Cachexia Syndrome (Oncology) therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Cancer Anorexia-Cachexia Syndrome (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Cancer Anorexia-Cachexia Syndrome (Oncology)
Reasons to buy
Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
Find and recognize significant and varied types of therapeutics under development for Cancer Anorexia Market-Cachexia Syndrome (Oncology).
Classify potential new clients or partners in the target demographic.
Develop tactical initiatives by understanding the focus areas of leading companies.
Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
Formulate corrective measures for pipeline projects by understanding Cancer Anorexia-Cachexia Syndrome (Oncology) pipeline depth and focus of Indication therapeutics.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Contact Info:
Name: Ritesh Tiwari
Email: sales@reportsandreports.com
Organization: ReportsnReports.com
For more information, please visit http://www.reportsnreports.com/reports/944648-cancer-anorexia-cachexia-syndrome-pipeline-review-h1-2017.html
Source: MarketersMedia
Release ID: 193404
Copyright © 1999-2013 SproutNews.com
